ID
30556
Description
https://clinicaltrials.gov/ct2/show/NCT00344006 Study ID : CDA 714703/005 Clinical Study ID :714703/005 Study Title :A multi-centre, randomised, double-blind, double dummy study comparing the efficacy and safety of chlorproguanil-dapsone-artesunate versus artemether-lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in children and adolescents in Africa. Patient Level Data : Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier : NCT00344006 Sponsor : GlaxoSmithKline Collaborators : N/A Phase phase :3 Study Recruitment Status : Completed Generic Name : artesunate/chlorproguanil/dapsone Trade Name : LAPDAP + ARTESUNATE Study Indication : Malaria, Falciparum
Link
https://clinicaltrials.gov/ct2/show/NCT00344006
Keywords
Versions (1)
- 6/14/18 6/14/18 - Halim Ugurlu
Copyright Holder
GlaxoSmithKline (GSK)
Uploaded on
June 14, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
NCT00344006-Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria
Case Report From, Module Number 2.1 (Concominant Medications, Anti-Malarial Rescue Concominant Medications)
Description
Concominant Medications
Alias
- UMLS CUI-1
- C2347852
Description
Concominant Medications
Alias
- UMLS CUI-1
- C2347852
Description
Drug Name
Data type
text
Alias
- UMLS CUI [1]
- C2360065
Description
Unit Dose
Data type
float
Alias
- UMLS CUI [1]
- C0869039
Description
Units
Data type
text
Alias
- UMLS CUI [1]
- C0439148
Description
Frequency
Data type
text
Alias
- UMLS CUI [1]
- C3476109
Description
Route
Data type
text
Alias
- UMLS CUI [1]
- C0013153
Description
Reason for medication
Data type
text
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C0013227
Description
Start Date
Data type
date
Alias
- UMLS CUI [1]
- C0808070
Description
Start Time
Data type
time
Alias
- UMLS CUI [1]
- C1301880
Description
Taken prior to study
Data type
boolean
Alias
- UMLS CUI [1]
- C2826667
Description
Stop Date
Data type
date
Alias
- UMLS CUI [1]
- C0806020
Description
Stop Time
Data type
time
Alias
- UMLS CUI [1]
- C1522314
Description
Ongoing Medication
Data type
boolean
Alias
- UMLS CUI [1]
- C2826666
Description
Anti-Malarial Rescue Concominant Medications
Alias
- UMLS CUI-1
- C2347852
- UMLS CUI-2
- C2193813
Description
Anti-Malarial Rescue Concominant Medications
Alias
- UMLS CUI-1
- C2347852
- UMLS CUI-2
- C2193813
Description
Drug Name
Data type
text
Alias
- UMLS CUI [1]
- C2360065
Description
Unit Dose
Data type
float
Alias
- UMLS CUI [1]
- C0869039
Description
Units
Data type
text
Alias
- UMLS CUI [1]
- C0439148
Description
Frequency
Data type
text
Alias
- UMLS CUI [1]
- C3476109
Description
Route
Data type
text
Alias
- UMLS CUI [1]
- C0013153
Description
Reason for medication
Data type
text
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C0013227
Description
Start Date
Data type
date
Alias
- UMLS CUI [1]
- C0808070
Description
Start Time
Data type
time
Alias
- UMLS CUI [1]
- C1301880
Description
Stop Date
Data type
date
Alias
- UMLS CUI [1]
- C0806020
Description
Stop Time
Data type
time
Alias
- UMLS CUI [1]
- C1522314
Description
Ongoing Medication
Data type
boolean
Alias
- UMLS CUI [1]
- C2826666
Similar models
Case Report From, Module Number 2.1 (Concominant Medications, Anti-Malarial Rescue Concominant Medications)
C2347852 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C2193813 (UMLS CUI-2)
C2193813 (UMLS CUI [1,2])
C2193813 (UMLS CUI-2)
C0013227 (UMLS CUI [1,2])